共 50 条
- [1] -308 A/G polymorphism in the tumor necrosis factor alpha gene influences outcome of etanercept treatment in Rheumatoid Arthritis (RA). [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S559 - S559
- [2] -308 A/G polymorphism in the tumor necrosis factor-α gene influences outcome of etanercept treatment in rheumatoid arthritis. [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S231 - S231
- [3] Influence of-308 A/G polymorphism in the tumor necrosis factor α gene on etanercept treatment in rheumatoid arthritis [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1426 - 1430
- [4] Polymorphism at position-308 of the tumor necrosis factor a gene influences outcome of infliximab therapy in rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (07): : 1849 - 1852
- [5] Tumor necrosis factor α haplotypes versus tumor necrosis factor α -: 308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4075 - 4076
- [7] Tumor necrosis factor α haplotypes versus tumor necrosis factor α -: 308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis -: Reply [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4076 - 4077